Proposed Settlement with Abbott Laboratories and Geneva Pharmaceuticals to Resolve Similar Charges over Generic Version of Abbott's Hytrin
|What:||The Federal Trade Commission will hold a news conference to announce law enforcement actions involving brand name and generic pharmaceutical manufacturers.|
|When:||Thursday, March 16, at 1:30 p.m.|
|Who:||Richard G. Parker, Director
FTC Bureau of Competition
|Where:||Federal Trade Commission
600 Pennsylvania Ave., NW
Washington, D.C. 20580
|Contact:||Mitchell J. Katz or Howard Shapiro
FTC Office of Public Affairs
202-326-2161 or 202-326-2176
Listen Only: Reporters unable to attend may listen to the event by calling: 1-888-790-3103.
Room 432 will open at 12:45 pm to allow camera crews time to set up.